ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,721Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 2061

$1.75M Total Retail Price of All Prescriptions

Rank: 22 out of 2061

787 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 787 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 787 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 23,317 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 1,189 955 1 6
LEVOTHYROXINE SODIUM 1,005 791 2 3
WARFARIN SODIUM 908 744 3 11
LISINOPRIL 861 697 4 2
SIMVASTATIN 713 553 5 1
OMEPRAZOLE 701 568 6 5
METOPROLOL TARTRATE 664 621 7 7
AMLODIPINE BESYLATE 660 570 8 4
MIRTAZAPINE 576 525 9 46
TRAMADOL HCL 460 414 10 18
TAMSULOSIN HCL 432 369 11 30
NAMENDA 426 424 12 37
HYDROCODONE-ACETAMINOPHEN 397 280 S3 13 10
POTASSIUM CHLORIDE 379 298 14 16
DONEPEZIL HCL 360 357 15 24
SERTRALINE HCL 354 280 16 21
TRAZODONE HCL 310 259 17 39
KLOR-CON M20 306 196 18 47
OXYCODONE-ACETAMINOPHEN 294 197 S2 19 36
FENTANYL 280 247 S2 20 84
GLIMEPIRIDE 278 228 21 33
CYMBALTA 277 214 22 59
ALBUTEROL SULFATE 272 264 23 104
DIVALPROEX SODIUM 266 179 24 74
QUETIAPINE FUMARATE 262 217 25 72
RISPERIDONE 262 216 25 66
LANTUS 260 179 27 48
CIPROFLOXACIN HCL 258 221 28 54
LYRICA 252 133 29 83
HYDROCHLOROTHIAZIDE 240 205 30 12
PREDNISONE 240 168 30 32
CITALOPRAM HBR 229 215 32 20
METHYLPREDNISOLONE 228 164 33 101
MELOXICAM 228 200 33 44
GABAPENTIN 226 131 35 15
LIDODERM 225 182 36 106
DOXYCYCLINE HYCLATE 225 155 36 98
ATORVASTATIN CALCIUM 209 150 38 8
ATENOLOL 208 187 39 13
EXELON 207 207 40 94
PANTOPRAZOLE SODIUM 205 169 41 45
METFORMIN HCL 197 146 42 9
IPRATROPIUM-ALBUTEROL 178 153 43 117
SULFAMETHOXAZOLE-TRIMETHOPRIM 172 127 44 87
FLUTICASONE PROPIONATE 170 125 45 43
ZOLPIDEM TARTRATE 168 135 46 23
METOPROLOL SUCCINATE 167 134 47 19
IPRATROPIUM BROMIDE 163 152 48 167
LEVETIRACETAM 162 147 49 102
AVELOX 160 138 50 254
CLOPIDOGREL 158 129 51 29
ESCITALOPRAM OXALATE 153 112 52 77
JANUVIA 149 117 53 51
ISOSORBIDE MONONITRATE ER 148 122 54 42
OXYBUTYNIN CHLORIDE ER 144 111 55 80
ALLOPURINOL 142 125 56 28
LOSARTAN POTASSIUM 141 117 57 17
FAMOTIDINE 141 98 57 67
GLIPIZIDE 139 112 59 55
LOVASTATIN 123 122 60 35
NEXIUM 122 66 61 26
SPIRIVA 120 94 62 63
ADVAIR DISKUS 118 65 63 57
CLONIDINE HCL 114 83 64 52
CARVEDILOL 114 111 64 22
PAROXETINE HCL 114 106 64 61
NYSTOP 110 84 67 185
BACLOFEN 107 46 68 123
PRAVASTATIN SODIUM 106 74 69 14
AMOX TR-POTASSIUM CLAVULANATE 106 88 69 113
PLAVIX 106 85 69 49
CARBIDOPA-LEVODOPA 105 105 72 97
VANCOMYCIN HCL 104 90 73 252
CYCLOBENZAPRINE HCL 104 63 R 73 78
AZITHROMYCIN 104 90 73 34
FLUCONAZOLE 101 61 76 200
CLOTRIMAZOLE-BETAMETHASONE 101 77 76 173
FLUOXETINE HCL 100 60 78 73
TRIAMCINOLONE ACETONIDE 99 73 79 172
DIGOXIN 98 80 80 56
NOVOLIN R 98 80 80 129
CEPHALEXIN 91 79 82 112
NYSTATIN 90 67 83 148
NOVOLOG 89 63 84 102
OLANZAPINE 88 64 85 132
RANITIDINE HCL 88 59 85 53
SPIRONOLACTONE 87 79 87 62
SEROQUEL 85 69 88 157
METRONIDAZOLE 84 81 89 223
ALENDRONATE SODIUM 84 74 89 25
HALOPERIDOL 82 71 91 153
ABILIFY 82 18 91 160
DOXAZOSIN MESYLATE 80 63 93 81
LACTULOSE 79 78 94 131
FINASTERIDE 78 66 95 86
CRESTOR 78 68 95 31
KETOCONAZOLE 76 56 97 230
POLYETHYLENE GLYCOL 3350 75 56 98 64
MEGESTROL ACETATE 73 73 R 99 198
HYDRALAZINE HCL 67 50 100 69
OXYCODONE HCL 67 30 S2 100 82
DIOVAN 66 66 102 41
SUCRALFATE 64 48 103 151
GENERLAC 63 58 104 233
LANTUS SOLOSTAR 63 38 104 76
ENOXAPARIN SODIUM 62 43 106 267
TOPIRAMATE 61 15 107 190
METHOTREXATE 59 45 108 182
SODIUM CHLORIDE 59 45 108 192
ROPINIROLE HCL 57 54 110 92
DILTIAZEM 24HR CD 56 56 111 118
TORSEMIDE 55 40 112 126
DALIRESP 55 40 112 513
KLOR-CON M10 53 35 114 125
CEFUROXIME 53 37 114 170
LEXAPRO 52 36 116 211
TIZANIDINE HCL 51 43 117 137
DEXTROSE WITH SODIUM CHLORIDE 51 46 117 409
NITROSTAT 50 41 119 226
HUMALOG 50 39 119 163
SANTYL 50 39 119 274
PROPRANOLOL HCL 50 17 119 143
AMOXICILLIN 50 47 119 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.